Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma

Merck and Moderna announce encouraging results for a new cancer vaccine aimed at preventing melanoma recurrence in high-risk patients. This innovative treatment combines an mRNA vaccine with Merck's Keytruda immunotherapy and shows potential in extending the time before cancer returns.

Full story and more reels: https://newsreel.video #news #breaking #cancerresearch #melanoma #vaccine #health #pharmaceuticals